---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-003418"
form_type: "8-K"
ticker: "GNVR"
cik: "0001792941"
company_name: "Genvor Inc"
filed_at: "2024-01-23T23:59:59+00:00"
generated_at: "2026-06-06T20:09:28.135877+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Genvor appoints Chad Pawlak CEO, reshuffles executive team; Miller becomes CBO and Interim CFO

## Summary
- Chad Pawlak appointed CEO with base salary of $300,000/year and up to 30% annual bonus tied to milestones.
- Judith Miller resigns as Interim CEO, becomes CBO and Interim CFO with base salary of $180,000/year plus monthly stock grants.
- Dr. Jesse Jaynes named Chief Scientific Officer; Dr. Clayton Yates resigns as CSO and becomes scientific advisor.
- Executives receive milestone-based equity: Pawlak eligible for up to 4 million shares upon achieving product and regulatory goals.
- Indemnification agreements entered into with all officers and directors effective January 17, 2024.

## SEC filing metadata
- accession: 0001493152-24-003418
- form_type: 8-K
- ticker: GNVR
- cik: 0001792941
- company_name: Genvor Inc
- filed_at: 2024-01-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-003418
- JSON: https://secwatch.observer/filing/0001493152-24-003418.json
- Plain text: https://secwatch.observer/filing/0001493152-24-003418.txt

## Key facts
- Executive change
  Judith S. Miller was appointed as member of the Board, Chief Business Officer, and Interim Chief Financial Officer at Genvor Inc.
  - Action: appointed
  - Role: member of the Board, Chief Business Officer, and Interim Chief Financial Officer
  source text: Judith S. Miller resigned as the Company’s Interim Chief Executive Officer and was appointed as a member of the Company’s Board of Directors (the “ Board ”), as the Chief Business Officer of the Company, and as the Interim Chief Financial Officer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm
- Executive change
  Dr. Jesse Jaynes was appointed as Chief Scientific Officer at Genvor Inc.
  - Action: appointed
  - Role: Chief Scientific Officer
  source text: Dr. Jesse Jaynes was appointed as the Chief Scientific Officer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm
- Executive change
  Dr. Clayton Yates was appointed as scientific advisor at Genvor Inc.
  - Action: appointed
  - Role: scientific advisor
  source text: Dr. Clayton Yates resigned as Chief Scientific Officer of the Company and was appointed as a scientific advisor for the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm
- Executive change
  Chad Pawlak was appointed as Chief Executive Officer at Genvor Inc.
  - Action: appointed
  - Role: Chief Executive Officer
  source text: Chad Pawlak was appointed as Chief Executive Officer of Genvor Incorporated
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.